Document:

Subscription Agreement

 

	 	As of December 25, 2011

 

To the Board of Directors of

Pacific Monument Acquisition Corporation:

 

Gentlemen:

 

The undersigned hereby subscribes for and agrees
to purchase an aggregate of 266,667 warrants (“Warrants”), each to purchase one share of common stock of Pacific Monument
Acquisition Corporation (the “Corporation”), at $0.75 per Warrant, for an aggregate purchase price of $200,000 (“Purchase
Price”), subject to a proportionate adjustment in the event the size of the IPO is reduced. The closing of the purchase of
the Warrants shall occur simultaneously with the consummation of the Corporation’s initial public offering of securities
(“IPO”). Morgan Joseph TriArtisan LLC is acting as representative of the underwriters in the IPO. The Warrants will
be sold to the undersigned on a private placement basis and not as part of the IPO.

 

At least 24 hours prior to the effective date
(“Effective Date”) of the registration statement filed in connection with the IPO (“Registration Statement”),
the undersigned shall wire the Purchase Price to Graubard Miller, as escrow agent (“Escrow Agent”), to hold in a non-interest
bearing account until the Corporation consummates the IPO. Simultaneously with the consummation of the IPO, the Escrow Agent shall
deposit the Purchase Price, without interest or deduction, into the trust fund (“Trust Fund”) established by the Corporation
for the benefit of the Corporation’s public shareholders as described in the Corporation’s Registration Statement,
pursuant to the terms of an Investment Management Trust Agreement to be entered into between the Corporation and Continental Stock
Transfer & Trust Company. In the event that the IPO is not consummated within 14 days of the date the Purchase Price is delivered
to the Escrow Agent, the Escrow Agent shall return the Purchase Price to the undersigned, without interest or deduction.

 

The undersigned represents and warrants that
it has been advised that the Warrants have not been registered under the Securities Act of 1933, as amended (the “Securities
Act”); that it is acquiring the Warrants for its account for investment purposes only; that it has no present intention of
selling or otherwise disposing of the Warrants in violation of the securities laws of the United States; that it is an “accredited
investor” as defined by Rule 501 of Regulation D promulgated under the Securities Act; that it is familiar with the proposed
business, management, financial condition and affairs of the Corporation; that it understands that if the Corporation does not
complete a Business Combination (defined below), the Warrants will expire worthless; that it has full corporate power and authority
to execute and deliver this letter and any documents contemplated herein or needed to consummate the transactions contemplated
in this letter; and that this letter constitutes the legal, valid and binding obligation of such undersigned and is enforceable
against such undersigned.

 

The undersigned agrees that it will not sell,
transfer, assign, pledge or hypothecate the Warrants (or the Common Stock underlying the Warrants) for a period of 180 days following
Effective Date pursuant to Rule 5110(g)(1) of the Conduct Rules of FINRA to anyone other than (i) an underwriter or selected
dealer in connection with the IPO, or (ii) a bona fide officer or partner of the undersigned or of any such underwriter or
selected dealer. On and after such 180 day period, transfers to others may be made subject to compliance with or exemptions from
applicable securities laws.

 

    	 

    	 

    

 

The undersigned agrees that it shall not sell
or transfer the Warrants or any underlying securities until after the Corporation consummates a merger, share exchange, asset acquisition,
share purchase, recapitalization, reorganization or other similar business combination (“Business Combination”) with
one or more businesses or entities (except for transfers (i) amongst the undersigned or the Corporation’s
officers, directors and employees, (ii) as a distribution to partners, affiliates, members, employees, consultants, stockholders
or beneficiaries of the undersigned, or (iii) by private sales at prices no greater than the price at which the Warrants were originally
purchased, in each case on the condition that such transfers may be implemented only upon the respective transferee’s written
agreement to be bound by the transfer restrictions of this Subscription Agreement and the Warrant Agreement to be entered
into between the Corporation and Continental Stock Transfer & Trust Company and filed as an exhibit
to the Registration Statement). The undersigned acknowledges that the certificates for such Warrants shall contain a legend
indicating such restriction on transferability.

 

The Warrants will be identical to the warrants
underlying the units being offered by the Corporation in the IPO except that they (i) will expire five years from the effective
date of the Registration Statement so long as they are held by the undersigned and its affiliates, (ii) shall
not be redeemable by the Corporation and (iii) shall be exercisable on a cashless basis by surrendering such Warrants for that
number of shares of the Corporation’s common stock equal to the quotient obtained by dividing (x) the product of the number
of shares of the Corporation’s common stock underlying the Warrants, multiplied by the difference between the Warrant exercise
price and the “Fair Market Value” (defined below) by (y) the Fair Market Value, in each case so long as the Warrants
are held by the undersigned or its permitted transferees; provided, however, that no cashless exercise shall be permitted unless
the Fair Market Value is higher than the exercise price. The “Fair Market Value” shall mean the average reported last
sale price of the shares of the Corporation’s common stock for the 10 trading days ending on the day prior to the date the
Corporation receives the exercise notice. The Corporation also agrees that the Warrants will be subject to customary registration
rights as described in the Registration Statement.

 

This Agreement shall be governed by and construed
in accordance with the laws of the State of New York for agreements made and to be wholly performed within such state. The parties
hereto hereby waive any right to a jury trial in connection with any litigation pursuant to this Agreement and the transactions
contemplated hereby.

 

	 	 	Very truly yours,
	 	 	 
	 	 	Morgan Joseph TriArtisan LLC
	 	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:

Agreed to:

 

Pacific Monument Acquisition Corporation

 

	By:	 	 
	 	Name:	 
	 	Title:	 

 

    	 

    	 

    

 

Graubard Miller, solely as Escrow Agent

 

	By:	 	 
	 	Name:	 
	 	Title:PACIFIC MONUMENT ACQUISITION CORPORATION

800 Third Avenue

New York, NY 10022

 

_______________, 2012

 

[Monument Capital Group SPAC I LLC]

[Pacific Capital Partners & Associates Limited]

 

 

Ladies and Gentlemen:

 

This letter will confirm our agreement that,
commencing on the effective date (the “Effective Date”) of the registration statement (the “Registration
Statement”) for the initial public offering (the “IPO”) of the securities of Pacific Monument
Acquisition Corporation (the “Company”) and continuing until the earlier of (i) the consummation by the
Company of an initial business combination or (ii) the liquidation of the Company’s trust account (defined below) (in each
case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”),
[Monument Capital Group SPAC I LLC][Pacific Capital Partners & Associates Limited] shall make available to the Company certain
office space and administrative and support services as may be required by the Company from time to time, situated at [800 Third
Avenue, New York, New York 10022][14th Floor, Albert Embankment, London, SE1 7TP] (or any successor location). In exchange
therefore, the Company shall pay ProChannel [Monument Capital Group SPAC I LLC][Pacific Capital Partners & Associates Limited]
the sum of $5,000 per month on the Effective Date and continuing monthly thereafter until the Termination Date. [Monument Capital
Group SPAC I LLC][Pacific Capital Partners & Associates Limited] hereby agrees that it does not have any right, title, interest
or claim of any kind in or to any monies that may be set aside in a trust account (the “Trust Account”)
that may be established upon the consummation of the IPO (the “Claim”) and hereby waives any Claim it
may have in the future as a result of, or arising out of, any negotiations, contracts or agreements with the Company and will not
seek recourse against the Trust Account for any reason whatsoever.

 

 

	 	 	Very truly yours,
	 	 	 
	 	 	PACIFIC MONUMENT ACQUISITION CORPORATION
	 	 	 
	 	By:	
	 	 	Name:
	 	 	Title:

 

AGREED TO AND ACCEPTED BY:

 

[Monument Capital Group
SPAC I LLC]

[PACIFIC CAPITAL PARTNERS & ASSOCIATES LIMITED]

 

 

	By:	 
	 	Name:
	 	Title:Unassociated Document

Exhibit 10.1.4

ASSIGNMENT AND ASSUMPTION AGREEMENT

(CAMBRIDGE, MASSACHUSETTS)

 

THIS ASSIGNMENT AND ASSUMPTION AGREEMENT (this “Agreement”), dated as of December 31, 2011, is made by and between ARIAD Corporation, a Delaware corporation (“Assignor”) and ARIAD Pharmaceuticals, Inc., a Delaware corporation (“Assignee”).

 

Background Statement

 

WHEREAS, UP 26 LANDSDOWNE, LLC, a Delaware limited liability company (“Landlord”), as successor in interest to Forest City Cambridge, Inc., an Ohio corporation, is the “Landlord” and Assignor, as successor in interest to Assignee via an Assignment and Assumption of Lease dated October 19, 1992 and recorded with the Middlesex County Southern District Registry of Deeds in Book 22527, Page 581, and filed with the Middlesex County Southern Registry District of the Land Court as Document 888025 noted on Certificate of Title No. 157415, is the “Tenant” under that certain Lease dated January 8, 1992, as amended by that certain First Amendment to Lease dated May 12, 1994, the Settlement Agreement and Second Amendment to Lease dated May 12, 1994, the Third Amendment to Lease dated June 1, 1994, a letter agreement dated December 16, 1996, a letter agreement dated November 5, 1997, a letter agreement dated July 31, 1998, a letter agreement dated November 30, 1998, the Sixth Amendment to Lease dated December 31, 1999, the Seventh Amendment to Lease dated March, 2001, the Notice of Extension of Lease dated October 2, 2001, and the Eighth Amendment to Lease dated October 30, 2006 (the “Lease”) for certain premises located at 26 Landsdowne Street, Cambridge, Massachusetts.

 

Statement of Agreement

 

NOW, THEREFORE, for good and valuable consideration, each to the other paid, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

 

	
  

	
1.

	
ASSIGNMENT AND ASSUMPTION. Assignor transfers, assigns and sets over unto the Assignee all of its right, title and interest in and to the Lease and in and to any security deposits and prepaid rent made by Assignor under the Lease, effective as of the date that Assignor has merged into Assignee (the “Effective Date”).  Assignee assumes the performance of and agrees to be bound by all the obligations of Assignor as tenant under the Lease arising on and after the Effective Date, including, without limitation, the obligation to pay monthly rent and other amounts provided for thereunder, and Assignee agrees that it will be directly liable to Landlord for all obligations arising under the Lease from and after the Effective Date.

 

	
  

	
2.

	
BINDING ON SUCCESSORS; MODIFICATION.  This Agreement shall be binding upon and inure to the benefit of the parties hereto, their successors in interest and assigns.  This Agreement may not be modified, discharged, terminated, or assigned orally or in any manner other than by an agreement in writing signed by the parties hereto or their respective successors and assigns.

 

 

  

  

  

 

	
  

	
3.

	
CONTROLLING LAW; COUNTERPARTS.  This Agreement shall be governed by and interpreted in accordance with the laws of the Commonwealth of Massachusetts.  This Agreement may be executed in counterparts and, taken together, such counterparts shall constitute one and the same Agreement, valid and binding on the parties.

 

SIGNATURES APPEAR ON FOLLOWING PAGE

 

 

  

- 2 -

  

 

IN WITNESS WHEREOF, Assignor and Assignee have signed and sealed this Agreement as of the day and year first above written.

 

	
ASSIGNOR:

	
ARIAD Corporation

	  	  
	  	
By: /s/ Harvey Berger

	  	
Name: Harvey J. Berger, MD

	  	
Its: President

	  	  
	
ASSIGNEE:

	
ARIAD Pharmaceuticals, Inc.

	  	  
	  	
By: /s/ Edward M. Fitzgerald

	  	
Name: Edward M. Fitzgerald

	  	
Its: Executive Vice President, CFO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00200-of-00352.parquet"}]]